Caribou Biosciences (CRBU) Other Non-Current Liabilities (2020 - 2022)

Caribou Biosciences (CRBU) has 3 years of Other Non-Current Liabilities data on file, last reported at $9000.0 in Q1 2022.

• On a quarterly basis, Other Non-Current Liabilities changed N/A year-over-year to $9000.0 in Q1 2022; TTM through Mar 2022 was $9000.0, a N/A change from a year earlier, with the FY2021 full-year figure at $17000.0, down 90.34% from the prior year.
• Other Non-Current Liabilities for Q1 2022 stood at $9000.0, down from $17000.0 in the prior quarter.
• Over the last five years, Other Non-Current Liabilities for CRBU reached as high as $176000.0 in Q4 2020 and fell as low as $9000.0 in Q1 2022.
• Historically, Other Non-Current Liabilities has averaged $103600.0 across 3 years, with a median of $153000.0 in 2021.
• On a YoY basis, Other Non-Current Liabilities climbed as much as 90.34% in 2021 and fell as far as 90.34% in 2021.
• Year by year, Other Non-Current Liabilities stood at $176000.0 in 2020, then sank by 90.34% to $17000.0 in 2021, then tumbled by 47.06% to $9000.0 in 2022.
• Per Business Quant data, the three most recent Other Non-Current Liabilities figures were $9000.0 in Q1 2022, $17000.0 in Q4 2021, and $153000.0 in Q3 2021.